PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

NCT07190469 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)
Advanced Solid Tumors Cancer

Interventions

DRUG: PQ203

Sponsor

ProteinQure Inc.